Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy

Analysis found a potential increased risk of major congenital malformations (MCMs) following in utero exposure to modafinil and/or armodafinil compared with the general population (13 of 102 prospective live births [13%] had MCMs, which is above population prevalence of ~3%).

Source:

JAMA Internal Medicine